Exact Mass: 250.04853260000002
Exact Mass Matches: 250.04853260000002
Found 142 metabolites which its exact mass value is equals to given mass value 250.04853260000002,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sulfadiazine
Sulfadiazine is only found in individuals that have used or taken this drug. It is one of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections. [PubChem]Sulfadiazine is a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase. This enzyme is needed for the proper processing of para-aminobenzoic acid (PABA) which is essential for folic acid synthesis. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EC - Intermediate-acting sulfonamides D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BA - Sulfonamides Antibacterial agent. It is used in some countries for control of bacterial disease in farmed fish. Not approved for aquacultural use in the USA D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides CONFIDENCE standard compound; EAWAG_UCHEM_ID 179 CONFIDENCE standard compound; INTERNAL_ID 1011
Diflunisal
Diflunisal, a salicylate derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with pharmacologic actions similar to other prototypical NSAIAs. Diflunisal possesses anti-inflammatory, analgesic and antipyretic activity. Though its mechanism of action has not been clearly established, most of its actions appear to be associated with inhibition of prostaglandin synthesis via the arachidonic acid pathway. Diflunisal is used to relieve pain accompanied with inflammation and in the symptomatic treatment of rheumatoid arthritis and osteoarthritis. N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BA - Salicylic acid and derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D004791 - Enzyme Inhibitors KEIO_ID D058
2-Hydroxy-6-oxo-6-(2-hydroxyphenoxy)-hexa-2,4-dienoate
Aureoquinone
A naphthoquinone that is 1,4-naphthoquinone substituted by hydroxy groups at positions 2, 5, 7,and 8 and methyl groups at positions 3 and 6. It is isolated from surface cultures of Aureobasidium and acts as a protease inhibitor.
4-methyl-3-[(2-nitrobenzyl)thio]-4H-1,2,4-triazole
1,4,5,8-tetrahydroxy-3-ethylnaphthalene-2,6-dione|3-Ethyl-1,4,5,8-Tetrahydroxy-2,6-naphthoquinone
2,5,6,7-tetrahydroxy-3-ethyl-1,4-naphthoquinone|3-Aethyl-2,5,6,7-tetrahydroxy-[1,4]naphthochinon|3-ethyl-2,5,6,7-tetrahydroxy-[1,4]naphthoquinone
5,7-Dihydroxy-6-(hydroxymethyl)-2-methoxy-1,4-naphthoquinone
6-Aethyl-2,3,7-trihydroxy-juglon|6-Ethyl-2,3,7-trihydroxy-juglon
5,6-dimethoxy-7,8-methylenedioxycoumarin|Isosabandin|Sabandin
6-ethyl-2,3,5,8-tetrahydroxy-1,4-naphthoquinone|ethylspinazarin
3,5,8-Trihydroxy-2-methoxy-6-methyl-naphtho-1,4-chinon|3,5,8-Trihydroxy-2-methoxy-6-methyl-[1,4]naphthochinon|3,5,8-trihydroxy-2-methoxy-6-methyl-[1,4]naphthoquinone|Nepenthone D|nepenthone-D
9-(2-Hydroxyethoxy)-6H-1,3-dioxolo[4,5-g][1]benzopyran-6-one
Diphenylphosphate
CONFIDENCE standard compound; INTERNAL_ID 2301 INTERNAL_ID 2301; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 8815
diflunisal
N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BA - Salicylic acid and derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D004791 - Enzyme Inhibitors
2H-1-Benzopyran-6-acetic acid, 7-hydroxy-8-methoxy-2-oxo-
4-(CHLOROMETHYL)-N-(5-METHYLISOXAZOL-3-YL)BENZAMIDE
[2-(3-METHYL-4-NITRO-PHENYL)-THIAZOL-4-YL]-METHANOL
2-Propenoic acid, 3-(2,1,3-benzothiadiazol-5-yl)-3-hydroxy-, ethyl ester
3-CHLORO-4-FLUORO-3-METHYLBENZHYDROL
C14H12ClFO (250.05606639999996)
(4-((4,5-Dihydrothiazol-2-yl)carbamoyl)phenyl)boronic acid
3-(3-Methyl-4-oxo-thiazolidin-2-ylideneamino)-benzoic acid
sodium,(E)-but-2-ene-1,4-diol,hydrogen sulfite,2-methyloxirane
5-CHLORO-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLICACIDETHYLESTER
Ethyl 3-(4-Chlorophenyl)-1H-Pyrazole-5-Carboxylate
(3-((4,5-Dihydrothiazol-2-yl)carbamoyl)phenyl)boronic acid
3-[2-Oxo-3-(trifluoromethyl)pyridin-1(2H)-yl]propanethioamide
C9H9F3N2OS (250.03876599999998)
2-[4-(2-amino-1,3-thiazol-4-yl)phenoxy]acetic acid
methyl 5-(4-chloro-3-methyl-phenyl)-1H-pyrazole-3-carboxylate
Ethyl 2-[(dimethylamino)methyl]-1,3-thiazole-4-carboxylate hydroc hloride (1:1)
2-[2-(4-hydroxyanilino)-1,3-thiazol-4-yl]acetic acid
2-((2-Nitro-4-(trifluoromethyl)phenyl)amino)ethanol
5-CHLORO-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLICACIDETHYLESTER
(1,3,5,7,9,11,13,15-OCTAKIS(DIMETHYLSILYLOXY)PENTACYCLO[9.5.1.1(3,9).1(5,15).1(7,13)]OCTASILOXANE
((1R,4S)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonyl chloride
2-(4-OXO-4,5,6,7-TETRAHYDRO-3H-CYCLOPENTA[4,5]THIENO[2,3-D]PYRIMIDIN-3-YL)ACETIC ACID
2-Bromodecanoic acid
A bromo fatty acid that is decanoic acid carrying a single bromo substituent at position 2.
4-Oxo-3-phenyl-2-thioxoimidazolidine-1-acetic acid
Tetrakis(hydroxymethyl)phosphonium chloride urea polymer
C5H16ClN2O5P (250.04853260000002)
1-(4-METHOXYPHENYL)-5-METHYL-1H-PYRAZOLE-4-CARBONYL CHLORIDE
5-(4-CHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE
Pyridine, 3-chloro-2-(1-pyrrolidinyl)-5-(trifluoromethyl)-
BICYCLO[2.2.1]HEPTANE-1-METHANESULFONYL CHLORIDE, 7,7-DIMETHYL-2-OXO-
4(1H)-Pyridazinone, 1-(3-chlorophenyl)-3-methoxy-6-methyl-
3-METHYL-4-OXO-4,5,6,7-TETRAHYDRO-BENZOFURAN-2-CARBOXYLIC ACID
(2E,5E)-6-(3,4-dihydroxyphenyl)-2-hydroxy-4-oxohexa-2,5-dienoic acid
(2Z,4E)-6-(2,3-dihydroxyphenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid
5-[(4-Hydroxy-3-methoxyphenyl)methylene]-2-imino-1,3-thiazolidin-4-one
[4-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl]-(2-oxiranyl)methanone
sulfadiazine
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EC - Intermediate-acting sulfonamides D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BA - Sulfonamides D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position. C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides